Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorKUHN, Johann
dc.contributor.authorOLIE, Valerie
dc.contributor.authorGRAVE, Clemence
dc.contributor.authorLE STRAT, Yann
dc.contributor.authorBONALDI, Christophe
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorJOLY, Pierre
dc.date.accessioned2024-10-17T08:38:46Z
dc.date.available2024-10-17T08:38:46Z
dc.date.issued2024-09-07
dc.identifier.issn1179-1349en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/202553
dc.description.abstractEnAIM: Myocardial infarction (MI) is a cardiovascular disease caused by necrosis of the myocardium, which places a heavy burden on patients. In France, the proportion of daily smokers remains high, reaching at 25.5% in 2020. We evaluated the impact of smoking reduction scenarios on the projection of MI prevalence, mean age of incident cases and number of MI prevented cases until 2035. METHODS AND RESULTS: The French government has introduced smoking cessation policies that have led to an annual decrease in smoking prevalence. Based on this annual decline, we implemented three scenarios (SC) simulating an annual decrease in the proportion of smokers aged over 35 (SC1: 1%, ie, natural evolution without intervention, SC2: 2%, SC3: 9.87%) and a fourth scenario (SC4) in which there is a complete discontinuation of smoking from 2024 onwards using MI hospitalization and demographic data, estimations for the proportion of daily smokers between 35 and 95 years and multi-state models. Between 2023 and 2035, MI prevalence increased from 3.18% to 4.23% in males and from 1.00% to 1.46% in females under SC1. MI prevalence was equal to 4.21%, 4.06%, and 3.82% in males and 1.45%, 1.40%, and 1.34% in females in 2035 according to SC2, SC3, and SC4, respectively. Compared with SC1, 0.68% MI cases would be prevented with SC2, 4.52% with SC3 and 10.34% with SC4, with almost half of cases being prevented before 65 years of age. The increase in the mean age of MI incident cases ranged from 3 to 4 years among males and from 1 to 2 years among females. CONCLUSION: While reducing tobacco use could substantially reduce the number of MI cases prevented, its prevalence would continue to increase due to the ageing population. An integrated prevention strategy that includes the leading cardiovascular risk factors should more efficiently reduce the future burden of MI.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enBurden
dc.subject.enMyocardial Infarction
dc.subject.enPrevalence
dc.subject.enProjection
dc.subject.enSmoking Prevalence
dc.subject.enTobacco
dc.title.enImpact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035
dc.title.alternativeClin Epidemiolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.2147/clep.S440815en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39262929en_US
bordeaux.journalClinical Epidemiology / Clin Epidemiolen_US
bordeaux.page605-616en_US
bordeaux.volume16en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04740979
hal.version1
hal.date.transferred2024-10-17T08:38:48Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Epidemiology%20/%20Clin%20Epidemiol&rft.date=2024-09-07&rft.volume=16&rft.spage=605-616&rft.epage=605-616&rft.eissn=1179-1349&rft.issn=1179-1349&rft.au=KUHN,%20Johann&OLIE,%20Valerie&GRAVE,%20Clemence&LE%20STRAT,%20Yann&BONALDI,%20Christophe&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record